-->

Beyond Medical Technologies Stock Gross Profit

DOCKF Stock  USD 0.45  0.07  13.46%   
Fundamental analysis of Beyond Medical allows traders to better anticipate movements in Beyond Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Last ReportedProjected for Next Year
Gross Profit-202.7 K-192.6 K
Gross Profit Margin(0.24)(0.25)
The Beyond Medical's current Gross Profit is estimated to increase to about (192.6 K). The current Gross Profit Margin is estimated to decrease to -0.25.
  
Build AI portfolio with Beyond Stock
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Beyond Medical Technologies Company Gross Profit Analysis

Beyond Medical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Beyond Medical Gross Profit

    
  (250.49 K)  
Most of Beyond Medical's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beyond Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Beyond Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Beyond Medical is extremely important. It helps to project a fair market value of Beyond Stock properly, considering its historical fundamentals such as Gross Profit. Since Beyond Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Beyond Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Beyond Medical's interrelated accounts and indicators.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Beyond Medical Technologies reported (250,491) of gross profit. This is 100.01% lower than that of the Machinery sector and 100.36% lower than that of the Industrials industry. The gross profit for all United States stocks is 100.0% higher than that of the company.

Beyond Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beyond Medical's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beyond Medical could also be used in its relative valuation, which is a method of valuing Beyond Medical by comparing valuation metrics of similar companies.
Beyond Medical is currently under evaluation in gross profit category among its peers.

Beyond Fundamentals

About Beyond Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:
Check out Beyond Medical Piotroski F Score and Beyond Medical Altman Z Score analysis.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.01
Revenue Per Share
(0)
Quarterly Revenue Growth
(0.92)
Return On Assets
(1.35)
Return On Equity
(1.89)
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.